| Literature DB >> 27774033 |
Erin Silverman1, Christine M Sapienza2, Sarah Miller3, Giselle Carnaby4, Charles Levy5, Hsiu-Wen Tsai6, Paul W Davenport6.
Abstract
Cough and swallow protect the lungs and are frequently impaired following traumatic brain injury (TBI). This project examined cough response to inhaled capsaicin solution challenge in a cohort of four young adults with a history of TBI within the preceding five years. All participants had a history of tracheostomy with subsequent decannulation and dysphagia after their injuries (resolved for all but one participant). Urge to cough (UTC) and cough response were measured and compared to an existing database of normative cough response data obtained from 32 healthy controls (HCs). Participants displayed decreased UTC and cough responses compared to HCs. It is unknown if these preliminary results manifest as a consequence of disrupted sensory (afferent) projections, an inability to perceive or discriminate cough stimuli, disrupted motor (efferent) response, peripheral weakness, or any combination of these factors. Future work should attempt to clarify if the observed phenomena are borne out in a larger sample of individuals with TBI, determine the relative contributions of central versus peripheral nervous system structures to cough sensory perceptual changes following TBI (should they exist), and formulate recommendations for systematic screening and assessment of cough sensory perception in order to facilitate rehabilitative efforts. This project is identified with the National Clinical Trials NCT02240329.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27774033 PMCID: PMC5059551 DOI: 10.1155/2016/6875210
Source DB: PubMed Journal: Can Respir J ISSN: 1198-2241 Impact factor: 2.409
Demographics of healthy controls (HCs) and participants with TBI.
| M/F | Age (yrs.) | Time since TBI (yrs.) | RLAS1 | MOCA2 | Education (yrs.) | Other PMH | ||
|---|---|---|---|---|---|---|---|---|
| TBI | 1 | F | 49 | 1.26 | VI | N/A | 18 | DVT, Asp PNA, GJ tube, double vision, and deafness |
| 2 | M | 22 | 2.10 | VIII | 23 | 12 | Rare dysphagia episodes (thin liquids) after TBI | |
| 3 | F | 20 | 0.55 | VIII | 24 | 12 | Heterotopic ossification s/p TBI, oropharyngeal dysphagia after TBI (resolved) | |
| 4 | M | 22 | 3.46 | VII | 25 | 15 | Dysphagia s/p TBI, reporting no symptoms currently | |
|
| ||||||||
| HCs | F ( | 23.60 (3.80) | N/A | N/A | N/A | |||
| M ( | 24.19 (3.96) | N/A | N/A | N/A | ||||
1Rancho Los Amigos Scale score [30]; 2Montreal Cognitive Assessment [31].
Average (SD) subjective UTC ratings (where 1 = no urge to cough and 10 = maximum urge to cough) and total cough count (CTot) at various concentrations of capsaicin in solution obtained from healthy controls (HCs) and participants with TBI.
| Capsaicin concentration ( | |||||
|---|---|---|---|---|---|
| 0 | 50 | 100 | 200 | 500 | |
| UTC (HC) | 1.09 (0.31) | 2.97 (1.11) | 4.12 (1.50) | 5.85 (1.85) | N/A |
| UTC (TBI) | 1.25 (0.50) | 2.88 (0.98) | 3.25 (1.22) | 4.50 (1.68) | 4.79 (0.85) |
| CTot (HC) | 0.00 (0.00) | 3.06 (2.31) | 4.81 (3.12) | 6.19 (3.58) | N/A |
| CTot (TBI) | 0.25 (0.5) | 1.13 (0.37) | 1.88 (1.07) | 2.83 (0.43) | 3.33 (0.72) |
500 μM capsaicin solution not administered to HC participants.
Figure 1Comparison of urge to cough (UTC) ratings at increasing concentrations of capsaicin, healthy controls (HCs) compared to participants with TBI. On this scale, 1 = “no urge to cough” and 10 = “maximum urge to cough.” Participants with TBI were presented with an additional three presentations of 500 μM capsaicin, for which there is no HC comparison data.
Figure 2Number of cough events (CTot) recorded following presentation of capsaicin solution at various consistencies; healthy controls (HCs) compared to participants with TBI. Participants with TBI were presented with an additional three presentations of 500 μM capsaicin, for which there is no HC comparison data.
Effect size calculations (Cohen's d) for UTC and CTot.
| Capsaicin concentration ( | Effect size (Cohen's | |
|---|---|---|
| UTC | Cough production | |
| 0 | −0.26 | 1.01 |
| 50 | −0.11 | −0.87 |
| 100 | −0.44 | −0.98 |
| 200 | −0.69 | −0.98 |
Percentage of HC and TBI participants producing a two-cough threshold response (C2) at various concentrations of capsaicin in solution.
| Capsaicin concentration ( | Percentage | |
|---|---|---|
| HC | TBI | |
| 0 | 3.13 | 0.00 |
| 50 | 71.88 | 0.00 |
| 100 | 12.50 | 25.00 |
| 200 | 9.38 | 75.00 |